4.7 Article

Genotype-phenotype correlation of X-linked Alport syndrome observed in both genders: a multicenter study in South Korea

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Urology & Nephrology

Guidelines for Genetic Testing and Management of Alport Syndrome

Judy Savige et al.

Summary: Genetic testing for pathogenic COL4A3?5 variants is crucial for investigating persistent hematuria and suspected inherited kidney diseases. Even in cases where a heterozygous pathogenic COL4A3 or COL4A4 is suspected, experts recommend genetic testing and cascade testing of family members to reduce the risk of kidney dysfunction. Testing for variants in the COL4A3?5 genes is also recommended for other kidney conditions such as proteinuria, steroid-resistant nephrotic syndrome, IgA glomerulonephritis, and kidney failure of unknown cause.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2022)

Article Urology & Nephrology

Digenic Alport Syndrome

Judy Savige et al.

Summary: Digenic Alport syndrome refers to the inheritance of pathogenic variants in COL4A5 plus COL4A3 or COL4A4, or in COL4A3 plus COL4A4. The consequences depend on sex, severity of COL4A5 variant, and nature of COL4A3 or COL4A4 change. In males with COL4A5 variant, all collagen IV ?3?4?5-heterotrimers are affected. In females with COL4A5 variant, on average 50% of heterotrimers are affected, increased to 75% with additional COL4A3 or COL4A4 variant. In digenic Alport syndrome with COL4A3 and COL4A4 variants, 75% of heterotrimers are affected. Inheritance is autosomal dominant or recessive based on variants' effect on the same or different chromosomes. This form of digenic disease results in increased proteinuria and median age of kidney failure intermediate between autosomal dominant and autosomal recessive Alport syndrome. Previous guidelines recommend identification and reporting of all pathogenic or likely pathogenic digenic variants, as well as identification and treatment of affected family members.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2022)

Review Urology & Nephrology

A Systematic Review of Pathogenic COL4A5 Variants and Proteinuria in Women and Girls With X-linked Alport Syndrome

Joel T. Gibson et al.

Summary: Proteinuria is correlated with a more severe genotype in women and girls with X-linked Alport syndrome, serving as an indicator of disease severity and likely progression.

KIDNEY INTERNATIONAL REPORTS (2022)

Article Pediatrics

An Update on Women and Girls with Alport Syndrome

Daniella Levy Erez et al.

Summary: Alport syndrome, a progressive hereditary disorder, has different manifestations in women depending on their genotype. Early diagnosis and treatment are important for women with Alport syndrome. Similar to men, women and girls with Alport syndrome are at risk for kidney disease and require monitoring and treatment.

CURRENT PEDIATRICS REPORTS (2022)

Article Urology & Nephrology

Mild X-linked Alport syndrome due to the COL4A5 G624D variant originating in the Middle Ages is predominant in Central/East Europe and causes kidney failure in midlife

Aleksandra M. Zurowska et al.

Summary: In a study of children with X-linked Alport Syndrome in Poland, a single variant in COL4A5 was identified as the predominant cause, dating back to a founder effect in the 12-13th century. This variant, known as G624D, was associated with a milder clinical course compared to other pathogenic variants, but still conferred a significant risk for kidney failure and deafness. Males with the G624D variant are candidates for both existing and emerging therapies for Alport Syndrome.

KIDNEY INTERNATIONAL (2021)

Review Urology & Nephrology

KDIGO 2021 CLINICAL PRACTICE GUIDELINE FOR THE MANAGEMENT OF GLOMERULAR DISEASES

Brad H. Rovin et al.

Summary: The KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases aims to assist clinicians caring for individuals with glomerular disease by providing actionable recommendations and valuable infographics. It also proposes research recommendations for areas where there are gaps in knowledge, targeting a broad audience of clinicians treating glomerular disease. The guideline development process followed an explicit evidence review and the treatment approaches are based on systematic reviews, evidence synthesis, and the GRADE approach.

KIDNEY INTERNATIONAL (2021)

Editorial Material Biochemistry & Molecular Biology

Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria

Judy Savige et al.

Summary: The meeting expanded the indications for screening for pathogenic variants in the COL4A5, COL4A3 and COL4A4 genes, refined the ACMG criteria for variant assessment, and identified mutational hotspots in the collagen IV alpha 5, alpha 3 and alpha 4 chains.

EUROPEAN JOURNAL OF HUMAN GENETICS (2021)

Article Urology & Nephrology

Prevalence Estimates of Predicted Pathogenic COL4A3-COL4A5 Variants in a Population Sequencing Database and Their Implications for Alport Syndrome

Joel Gibson et al.

Summary: This study estimated the frequencies of predicted pathogenic COL4A3-COL4A5 variants in populations without known kidney disease. The COL4A5 variants were found in at least one in 2320 individuals, and the predicted pathogenic heterozygous COL4A3 and COL4A4 variants affected one in 106 of the population. The results suggest the population frequencies for Alport syndrome need to be adjusted for individual variant penetrance and other factors.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

Article Pediatrics

Clinical practice recommendations for the diagnosis and management of Alport syndrome in children, adolescents, and young adults-an update for 2020

Clifford E. Kashtan et al.

Summary: According to recent developments, treatment is recommended to start immediately upon diagnosis in males with X-linked Alport syndrome and autosomal recessive Alport syndrome. Treatment is also recommended to begin at the onset of microalbuminuria in females with X-linked Alport syndrome and in males and females with autosomal dominant Alport syndrome.

PEDIATRIC NEPHROLOGY (2021)

Article Urology & Nephrology

Trimerization and Genotype-Phenotype Correlation of COL4A5 Mutants in Alport Syndrome

Misato Kamura et al.

KIDNEY INTERNATIONAL REPORTS (2020)

Article Medicine, General & Internal

X-Linked Alport Syndrome in Women: Genotype and Clinical Course in 24 Cases

Antonio Mastrangelo et al.

FRONTIERS IN MEDICINE (2020)

Review Urology & Nephrology

Genetic background, recent advances in molecular biology, and development of novel therapy in Alport syndrome

Kandai Nozu et al.

KIDNEY RESEARCH AND CLINICAL PRACTICE (2020)

Review Pediatrics

Expert consensus guidelines for the genetic diagnosis of Alport syndrome

Judy Savige et al.

PEDIATRIC NEPHROLOGY (2019)

Article Urology & Nephrology

A review of clinical characteristics and genetic backgrounds in Alport syndrome

Kandai Nozu et al.

CLINICAL AND EXPERIMENTAL NEPHROLOGY (2019)

Article Medicine, General & Internal

Keratoconus in a patient with Alport syndrome: A case report

Majid Moshirfar et al.

WORLD JOURNAL OF CLINICAL CASES (2019)

Article Pediatrics

Early Hearing Detection and Vocabulary of Children With Hearing Loss

Christine Yoshinaga-Itano et al.

PEDIATRICS (2017)

Article Urology & Nephrology

Natural History and Genotype-Phenotype Correlation in Female X-Linked Alport Syndrome

Tomohiko Yamamura et al.

KIDNEY INTERNATIONAL REPORTS (2017)

Review Urology & Nephrology

Ocular Features in Alport Syndrome: Pathogenesis and Clinical Significance

Judy Savige et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)

Article Public, Environmental & Occupational Health

The global burden of disabling hearing impairment: a call to action

Bolajoko O. Olusanya et al.

BULLETIN OF THE WORLD HEALTH ORGANIZATION (2014)

Article Urology & Nephrology

Milder clinical aspects of X-linked Alport syndrome in men positive for the collagen IV α5 chain

Yuya Hashimura et al.

KIDNEY INTERNATIONAL (2014)

Article Urology & Nephrology

Genotype-Phenotype Correlation in X-Linked Alport Syndrome

Mir Reza Bekheirnia et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)

Article Pediatrics

A family with X-linked benign familial hematuria

Kazunari Kaneko et al.

PEDIATRIC NEPHROLOGY (2010)

Article Pediatrics

Mutational analysis of COL4A5 gene in Korean Alport syndrome

HI Cheong et al.

PEDIATRIC NEPHROLOGY (2000)